These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 7601953)

  • 1. The Muir-Torre syndrome: a 25-year retrospect.
    Schwartz RA; Torre DP
    J Am Acad Dermatol; 1995 Jul; 33(1):90-104. PubMed ID: 7601953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
    Abbas O; Mahalingam M
    J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muir-Torre syndrome.
    Johnson PJ; Heckler F
    Ann Plast Surg; 1998 Jun; 40(6):676-7. PubMed ID: 9641292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasms.
    Schwartz RA; Goldberg DJ; Mahmood F; DeJager RL; Lambert WC; Najem AZ; Cohen PJ
    Dermatologica; 1989; 178(1):23-8. PubMed ID: 2917677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with a new-onset cutaneous sebaceous neoplasm following immunosuppression should be evaluated for Muir-Torre syndrome with germline mismatch repair gene mutation analysis: case reports.
    Cohen PR; Kurzrock R
    Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muir-Torre syndrome.
    Ponti G; Ponz de Leon M
    Lancet Oncol; 2005 Dec; 6(12):980-7. PubMed ID: 16321766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature.
    Akhtar S; Oza KK; Khan SA; Wright J
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):681-6. PubMed ID: 10534628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genitourinary tumors in men with the Muir-Torre syndrome.
    Davis DA; Cohen PR
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):909-12. PubMed ID: 7593809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
    Ponti G; Manfredini M; Tomasi A; Pellacani G
    Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muir-Torre syndrome.
    Cohen PR; Kohn SR; Davis DA; Kurzrock R
    Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
    Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
    Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muir-Torre syndrome (MTS): An update and approach to diagnosis and management.
    John AM; Schwartz RA
    J Am Acad Dermatol; 2016 Mar; 74(3):558-66. PubMed ID: 26892655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sebaceous lesions and their associated syndromes: part II.
    Eisen DB; Michael DJ
    J Am Acad Dermatol; 2009 Oct; 61(4):563-78; quiz 579-80. PubMed ID: 19751880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
    Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
    Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sebaceous hyperplasia of the lower eyelid].
    Spraul CW; Jakobczyk-Zmija MJ; Lang GK
    Klin Monbl Augenheilkd; 1999 Nov; 215(5):319-20. PubMed ID: 10609249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of multiple sebaceous epithelioma: analysis of microsatellite instability.
    Ueda M; Wang Y; Sugimura H; Tamura S; Kondoh M; Ichihashi M
    J Dermatol; 1999 Mar; 26(3):178-82. PubMed ID: 10209926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of Muir-Torre syndrome with a keratoacanthoma and sebaceous neoplasms: Clinicopathological features and a speculation on the pathogenesis of cutaneous tumor type.
    Takayama E; Yoshioka A; Takai T; Goto K
    J Dermatol; 2021 May; 48(5):690-694. PubMed ID: 33523490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muir-Torre syndrome in a haemodialysis patient.
    Godfrey ED; Coward RA; Gharpuray-Pandit D; Lalloo F; McKirdy S; Woywodt A
    Clin Kidney J; 2013 Aug; 6(4):414-7. PubMed ID: 27293570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.
    Roberts ME; Riegert-Johnson DL; Thomas BC; Rumilla KM; Thomas CS; Heckman MG; Purcell JU; Hanson NB; Leppig KA; Lim J; Cappel MA
    Genet Med; 2014 Sep; 16(9):711-6. PubMed ID: 24603434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple sebaceous tumors with colon cancer--Muir-Torre syndrome].
    Vajda A; Scharrer K; Baló-Banga JM
    Orv Hetil; 2003 May; 144(20):985-9. PubMed ID: 12830729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.